気道ステント - 世界市場の考察、競合情勢、市場予測（2030年）

世界の気道ステントの市場規模は、2024年～2030年の予測期間にCAGRで7.73％の成長が見込まれます。気道ステント需要の増加は、主に肺がんと呼吸器疾患の有病率の増加に起因します。さらに、内視鏡治療、気管支鏡検査などの治療法の高い採用率や、低侵襲手術への選好の高まりも、このデバイスの市場成長を促進する見込みです。さらに、呼吸器のリアルタイムデータ収集などの技術の進歩が世界中で市場を強化し、2024年～2030年の予測期間に気道ステント市場の成長に寄与すると見られます。

気道ステントの市場力学

気道ステント市場は、さまざまな理由により製品需要が伸びています。

世界中での肺がんや呼吸器疾患の有病率の増加が市場を強化すると予測されています。例えば、世界保健機関（WHO）（2022）によると、がんは世界の主要死因であり、2020年の死亡者数は約1,000万人、死亡者数の約6人に1人を占めます。同資料によると、2020年に世界で221万人近くが肺がんに罹患していると推定されています。肺がんのために気道の一部がふさがり、呼吸が困難になります。気道ステントを気道に挿入することで気道を確保し、呼吸を楽にします。したがって、肺がんの有病率の増加は、気道ステントの需要を増加させ、2022年～2028年の予測期間において、このデバイスの全体的な市場成長を促進すると予測されます。

さらに、多くの呼吸器系疾患の有病率の増加は、市場での製品需要を増加させます。例えば、気道ステントは気管気管支軟化症の治療に使用されます。この状態では気道が弱くなり、呼吸プロセスが困難になります。この症状は、気道ステントを挿入することで治すことができます。したがって、呼吸器疾患の有病率の増加は、市場における気道ステントの需要を増加させ、このデバイスの全体的な市場成長を強化する可能性があります。

さらに、低侵襲手術に対する需要と意識の高まりも、気道ステントの需要を増加させ、2022年～2028年の予測期間における気道ステントの全体的な市場成長を増加させる見込みです。

しかし、デバイスの厳しい規制承認や遠隔地における熟練した専門家の不足が、気道ステント市場の成長を妨げる可能性があります。

進行中のCOVID-19パンデミックも、気道ステント市場に若干の影響を与えています。疾患の発生当初は、ウイルスの蔓延を抑えるために厳格なロックダウンが課されたため、大幅な品不足となりました。がんやその他の慢性疾患の患者の入院は、COVID-19に罹患している患者に比べて低い優先順位にありました。一部の医療機器の生産も停止されました。さらに、パンデミックの間、手術は一時的に中止されました。COVID-19の感染リスクを減らすため、医師は準緊急症例や選択的症例を延期したりキャンセルしたりしました。しかし、大衆がワクチン接種を受けたことで、気道ステント市場は勢いを取り戻しました。

気道ステント市場のセグメント分析

気道ステント市場のタイプセグメントでは、気管気管支ステントが2023年の気道ステント市場で大きなシェアを占めると推定されます。これは、気管気管支ステントに関連するさまざまな利点と幅広い応用範囲によるものと見られます。

気管気管支ステントは、肺がんや慢性閉塞性肺疾患（COPD）などのさまざまな呼吸器疾患などのさまざまな適応症で使用されます。例えば、世界保健機関（WHO）（2022）が発表したデータによると、COPDは世界第3位の死因であり、2019年に323万人の死亡を引き起こしたと推定されています。さらに、COPDによる死亡の90％近くは、低中所得国の70歳未満の患者でした。さらにCOPDは、呼吸困難、咳、痰の発生など、持続的かつ進行性の呼吸器症状を引き起こします。COPDの有病率の増加は、気道ステントがCOPD症状の治療に使用されることから、市場におけるこのデバイスの需要を増加させます。したがって、上記の要因が予測期間におけるこのデバイスの全体的な市場成長を促進すると予測されます。

当レポートでは、世界の気道ステント市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 気道ステント市場レポートのイントロダクション

第2章 気道ステント市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価
• 財務ベンチマーク

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 気道ステント市場の主な要因の分析

• 気道ステント市場の促進要因
  • 肺がんと呼吸器疾患の有病率の増加
  • 内視鏡治療、気管支鏡検査などの治療法の高い採用率、低侵襲手術への選好の高まり
  • 呼吸器のリアルタイムデータ収集などの技術の進歩
• 気道ステント市場の抑制要因と課題
  • デバイスの厳格な規制承認
  • 遠隔地における熟練した専門家の不足
• 気道ステント市場の機会
  • 研究開発活動に対する政府の資金提供の増加

第5章 気道ステント市場のポーターのファイブフォース分析

第6章 気道ステント市場に対するCOVID-19の影響分析

第7章 気道ステント市場のレイアウト

• タイプ別
  • 気管気管支ステント
  • 喉頭ステント
• 材料タイプ別
  • 金属ステント
  • シリコンステント
  • ハイブリッドステント
• 製品タイプ別
  • 自己拡張型ステント
  • 非拡張型ステント
• エンドユーザー別
  • 病院
  • 外来手術センター
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 気道ステント市場：世界の企業シェア分析 - 主要3～5社

第9章 気道ステント市場の企業と製品のプロファイル

• Boston Scientific Corporation
• TAEWOONG
• MICRO-TECH (Nanjing) Co., Ltd.
• Novatech SA
• Boston Medical Products Inc.
• HOOD LABORATORIES.
• Merit Medical Systems.
• Cook
• Meditek Systems Pvt. Ltd.
• Stening SRL
• Fuji Systems
• Olympus
• Kapitex Healthcare Ltd
• Teleflex Incorporated.
• EFER ENDOSCOPY

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項と連絡先

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Airway stents Market in Global (2021-2030)
• Table 4: Airway stents Market in Global by Type (2021-2030)
• Table 5: Airway stents Market in Global by Material Type (2021-2030)
• Table 6: Airway stents Market in Global by Product Type (2021-2030)
• Table 7: Airway stents Market in Global by End User (2021-2030)
• Table 8: Airway stents Market in Global by Geography (2021-2030)
• Table 9: Airway stents Market in North America (2021-2030)
• Table 10: Airway stents Market in North America by Country (2021-2030)
• Table 11: Airway stents Market in the US (2021-2030)
• Table 12: Airway stents Market in Canada (2021-2030)
• Table 13: Airway stents Market in Mexico (2021-2030)
• Table 14: Airway stents Market in Europe (2021-2030)
• Table 15: Airway stents Market in Europe by Country (2021-2030)
• Table 16: Airway stents Market in France (2021-2030)
• Table 17: Airway stents Market in Germany (2021-2030)
• Table 18: Airway stents Market in the United Kingdom (2021-2030)
• Table 19: Airway stents Market in Italy (2021-2030)
• Table 20: Airway stents Market in Spain (2021-2030)
• Table 21: Airway stents Market in Russia (2021-2030)
• Table 22: Airway stents Market in Rest of Europe (2021-2030)
• Table 23: Airway stents Market in APAC (2021-2030)
• Table 24: Airway stents Market in APAC by Country (2021-2030)
• Table 25: Airway stents Market in China (2021-2030)
• Table 26: Airway stents Market in Japan (2021-2030)
• Table 27: Airway stents Market in India (2021-2030)
• Table 28: Airway stents Market in Australia (2021-2030)
• Table 29: Airway stents Market in South Korea (2021-2030)
• Table 30: Airway stents Market in Rest of APAC (2021-2030)
• Table 31: Airway stents Market in Rest of World (2021-2030)
• Table 32: Airway stents Market in RoW by Region (2021-2030)
• Table 33: Airway stents Market in Middle East (2021-2030)
• Table 34: Airway stents Market in Africa (2021-2030)
• Table 35: Airway stents Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Airway stents Market in Global (2021-2030)
• Figure 4: Airway stents Market in Global by Type (2021-2030)
• Figure 5: Airway stents Market in Global by Material Type (2021-2030)
• Figure 6: Airway stents Market in Global by Product Type (2021-2030)
• Figure 7: Airway stents Market in Global by End User (2021-2030)
• Figure 8: Airway stents Market in Global by Geography (2021-2030)
• Figure 9: Airway stents Market in North America (2021-2030)
• Figure 10: Airway stents Market in North America by Country (2021-2030)
• Figure 11: Airway stents Market in the US (2021-2030)
• Figure 12: Airway stents Market in Canada (2021-2030)
• Figure 13: Airway stents Market in Mexico (2021-2030)
• Figure 14: Airway stents Market in Europe(2021-2030)
• Figure 15: Airway stents Market in Europe by Country (2021-2030)
• Figure 16: Airway stents Market in France (2021-2030)
• Figure 17: Airway stents Market in Germany (2021-2030)
• Figure 18: Airway stents Market in the United Kingdom (2021-2030)
• Figure 19: Airway stents Market in Italy (2021-2030)
• Figure 20: Airway stents Market in Spain (2021-2030)
• Figure 21: Airway stents Market in Russia (2021-2030)
• Figure 22: Airway stents Market in Rest of Europe (2021-2030)
• Figure 23: Airway stents Market in APAC (2021-2030)
• Figure 24: Airway stents Market in APAC by Country (2021-2030)
• Figure 25: Airway stents Market in China (2021-2030)
• Figure 26: Airway stents Market in Japan (2021-2030)
• Figure 27: Airway stents Market in India (2021-2030)
• Figure 28: Airway stents Market in Australia (2021-2030)
• Figure 29: Airway stents Market in South Korea (2021-2030)
• Figure 30: Airway stents Market in Rest of APAC (2021-2030)
• Figure 31: Airway stents Market in Rest of World (2021-2030)
• Figure 32: Airway stents Market in RoW by Region (2021-2030)
• Figure 33: Airway stents Market in Middle East (2021-2030)
• Figure 34: Airway stents Market in Africa (2021-2030)
• Figure 35: Airway stents Market in South America (2021-2030)
• Figure 36: Market Drivers
• Figure 37: Market Barriers
• Figure 38: Marker Opportunities
• Figure 39: PORTER'S Five Force Analysis

Airway Stents Market By Type (Tracheobronchial Stents And Laryngeal Stents), By Material Type (Metal Stents [Nitinol Stents, Stainless Steel Stents, And Other Metal Stents], Silicone Stents, And Hybrid Stents), By Product Type (Self-Expandable Stents And Non-Expandable Stents), By End-User (Hospitals, Ambulatory Surgical Centers And Others), by geography is expected to grow at a healthy CAGR forecast till 2030 owing to an increasing prevalence of lung cancer and respiratory diseases and rising preference for minimally invasive surgeries

Global airway stents market is expected to grow at a CAGR of 7.73% during the forecast period from 2024 to 2030. The increase in demand for airway stents is primarily attributed to the increasing prevalence of lung cancer and respiratory diseases. Moreover, high adoption of therapeutic treatments such as endoscopic therapy, bronchoscopy, and other treatments and rising preference for minimally invasive surgeries will propel the market growth of the device. Further, the technological advancements such as real-time data collection of the respiratory tract, and other advancements across the world are anticipated to bolster the market, thereby contributing to the growth of the airway stents market during the forecast period from 2024-2030.

Airway Stents Market Dynamics:

The airway stents market is witnessing a growth in product demand owing to various reasons.

The increasing prevalence of lung cancer and respiratory disorders, across the world are anticipated to bolster the market. For instance, according to World Health Organization (WHO) 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. As per the same source, it was estimated that nearly 2.21 million people were suffering from lung cancer globally in the year 2020. Due to the lung cancer, the airway is partly blocked making it difficult for a patient to breathe. Airway stents are inserted in the airway to keep it open, leading to easy breathing. Thus, the increasing prevalence of lung cancer will increase the demand of airway stents, thereby anticipated to propel the overall market growth of the device in the forecast period of 2022 - 2028.

Additionally, increasing prevalence of many respiratory disorders will increase the product demand in the market. For instance, airway stents are used to treat tracheobronchomalacia. In this condition, the airway becomes weak making the breathing process difficult. The condition can be cured by inserting an airway stent. Thus, the increasing prevalence of respiratory disorder may increase the demand of airway stents in the market, bolstering the overall market growth of the device.

Moreover, the increasing demand and awareness of minimally invasive surgeries will also increase the demand of the airway stents, thereby increasing the overall market growth of airway stents in the forecast period of 2022 - 2028.

However, stringent regulatory approvals of the device and the dearth of skilled professionals in remote regions may hamper the airway stents market growth.

The ongoing COVID-19 pandemic has also slightly impacted the market for airway stents. At the onset of the disease, there was a significant shortage, attributed to the imposition of stringent lockdowns to curb the spread of the virus. Hospital admissions for patients that are suffering from cancers and other chronic disorders were not a priority in comparison to the patients suffering from coronavirus. Production of some medical devices was also shut down. Furthermore, the surgeries were temporarily stopped during the pandemic. To reduce the COVID-19 transmission risk, the physician have either postponed or canceled the semi-urgent and elective cases. However, with masses being vaccinated, the airway stents market has picked momentum.

Airway Stents Market Segment Analysis:

Airway stents Market by Type (Tracheobronchial Stents and Laryngeal Stents), by Material Type (Metal Stents [Nitinol Stents, Stainless Steel Stents, and Other Metal Stents], Silicone Stents, and Hybrid Stents), By Product Type (Self-Expandable Stents and Non-Expandable Stents), By End-User (Hospitals, Ambulatory Surgical Centers and Others), By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the airway stents market, the tracheobronchial stents are estimated to hold a significant share in the airway stents market in the year 2023. This can be ascribed to the various advantages and a wide application circle that is associated with tracheobronchial stents.

The tracheobronchial stents are used in various indications like lung cancer and various respiratory disorders such as chronic obstructive pulmonary disorder (COPD). For instance, according to data published by World Health Organization (WHO) 2022, it was estimated that COPD was the third leading cause of death worldwide, causing 3.23 million deaths in the year 2019. Additionally, nearly 90% of COPD deaths were those in patients under 70 years of age in low- and middle-income countries. Moreover, COPD causes persistent and progressive respiratory symptoms, including difficulty in breathing, cough and phlegm production. The increasing prevalence of COPD will increase the demand of airway stents as they are used to treat the COPD symptoms, thereby increasing the demand of the device in the market. Therefore, the above factor is anticipated to propel the overall market growth of the device in the forecast period.

Moreover, the product launches, in turn, drive the product demand in the market. For instance, in February 2022, Micro-Tech Endoscopy, announced that the company has introduced the first self-expanding tracheobronchial nitinol y-stent. The Y-Shaped Tracheal Stent System is designed to be a flexible, and compliant device to aid in the treatment of malignant neoplasms at the tracheobronchial carina.

Thus, owing to the various advantages like high-resolution, larger magnification offered by the electron microscopes and an increase in the launch and approvals of electron microscopes, there will be an increase in the demand for electron microscopes, which in turn will drive the airway stents market growth.

North America is expected to dominate the overall Airway Stents Market:

Among all the regions, North America is estimated to achieve a significant share in the global airway stents market. The increasing prevalence of lung cancer and respiratory diseases and rising preference for minimally invasive surgeries will increase the demand for airway stents in North America, leading to a rise in the overall airway stents market growth.

For instance, as per the data published by Centers for Disease Control and Prevention (CDC) 2020, it was estimated that in the year 2019 in the United States, 221,097 new cases of Lung and Bronchus cancer were reported, and 139,601 people had died of this cancer. As per the same source, it was also concluded that for every 100,000 people, 53 new Lung and Bronchus cancer cases were reported and 33 people died of this cancer. Moreover, as per the CDC study cancer is the second leading cause of death in the United States, exceeded only by heart disease. One of every four deaths in the United States is due to cancer. The increasing prevalence and the mortality rate can be controlled by providing accurate treatment at the relevant stage of the disease. Airway blockage due to lung cancer can be cured by inserting an airway stent. Thus, the increasing prevalence of lung cancer in the region will increase the product demand ultimately propelling the overall market growth in the forecast period of 2022 - 2028.

Moreover, the increasing use of tobacco is one of the major risk factor of lung cancer and for many respiratory disorders. For instance, as per the data given by CDC 2022, it was estimated that in the year 2020, nearly 13 of every 100 U.S. adults aged 18 years or older smoked cigarettes. Additionally, as per the same source, cigarette smoking remains the leading cause of preventable disease, disability, and death in the United States, accounting for more than 480,000 deaths every year, or about 1 in 5 deaths. Thus, the increasing consumption of tobacco may increase the risk of development of lung cancer and respiratory ailments. These disorders can be cured by inserting an airway stents through a surgical procedure. Thus, the increasing prevalence of lung cancer and respiratory disorder will increase the demand of the device in the market thereby, increasing the overall market growth of the airway stents in the North America in the year 2023 - 2028.

Thus, all the above-mentioned factors are anticipated to propel the market for airway stents in the North America.

Airway Stents Market Key Players:

Some of the key market players operating in the airway stents market include Boston Scientific Corporation, TAEWOONG, MICRO-TECH (Nanjing) Co., Ltd., Novatech SA, Boston Medical Products Inc., HOOD LABORATORIES., Merit Medical Systems., Cook, Meditek Systems Pvt. Ltd., Stening SRL, Fuji Systems, Olympus, Kapitex Healthcare Ltd, Teleflex Incorporated., EFER ENDOSCOPY, among others.

Recent Developmental Activities in the Airway Stents Market:

In January 2020, The U.S. Food and Drug Administration has cleared 3D-printed, patient-specific airway stents developed by Cleveland Clinic's, a nonprofit American academic medical center based in Cleveland, Ohio.

Key Takeaways from the Airway Stents Market Report Study

• Market size analysis for current airway stents market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the airway stents market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global airway stents market.
• Various opportunities available for the other competitor in the airway stents market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current airway stents market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for airway stents market growth in the coming future?

Target Audience who can be benefited from this Airway Stents Market Report Study

• Airway stents products providers
• Research organizations and consulting companies
• Airway stents-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in airway stents
• Various End-users who want to know more about the airway stents market and latest technological developments in the airway stents market.

Frequently Asked Questions for Airway Stents Market:

1. What are Airway stents?

An airway stents, also known as tracheobronchial prostheses, is a medical device with tube-shape and a hollow lumen that is inserted into an airway. They are usually placed bronchoscopically and can be used to treat a variety of large airway diseases.

2. What is the market for Global Airway stents?

Global airway stents market is expected to grow at a CAGR of 7.73% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Airway stents Market?

The airway stents market is witnessing a positive market growth owing to the increasing prevalence of lung cancer and respiratory diseases. Additionally, high adoption of therapeutic treatments such as endoscopic therapy, bronchoscopy, and other treatments and rising preference for minimally invasive surgeries will propel the market growth of the device. Furthermore, the technological advancements such as real-time data collection of the respiratory tract across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global Airway stents Market?

Some of the key market players operating in the airway stents market include Boston Scientific Corporation, TAEWOONG, MICRO-TECH (Nanjing) Co., Ltd., Novatech SA, Boston Medical Products Inc., HOOD LABORATORIES., Merit Medical Systems., Cook, Meditek Systems Pvt. Ltd., Stening SRL, Fuji Systems, Olympus, Kapitex Healthcare Ltd, Teleflex Incorporated., EFER ENDOSCOPY, others.

5. Which region has the highest share in Airway stents Market?

North America is expected to hold the highest share in the revenue in the airway stents market during the forecast period. Increasing prevalence of lung cancer and respiratory diseases and rising preference for minimally invasive surgeries will increase the demand for airway stents in North America, leading to a rise in the overall airway stents market growth in this region.

Table of Contents

1.Airway stents Market Report Introduction

2.Airway stents Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Airway stents Market Key Factors Analysis

• 4.1. Airway stents Market Drivers
  • 4.1.1. Increasing prevalence of lung cancer and respiratory diseases
  • 4.1.2. High adoption of therapeutic treatments such as endoscopic therapy, bronchoscopy, and other treatments and rising preference for minimally invasive surgeries
  • 4.1.3. The technological advancements such as real-time data collection of the respiratory tract
• 4.2. Airway stents Market Restraints and Challenges
  • 4.2.1. Stringent regulatory approvals of the device
  • 4.2.2. Dearth of skilled professionals in remote regions
• 4.3. Airway stents Market Opportunities
  • 4.3.1. Increased government funding for research and developmental activities

5. Airway stents Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Airway stents Market

7. Airway stents Market Layout

• 7.1. By Type
  • 7.1.1. Tracheobronchial Stents
  • 7.1.2. Laryngeal Stents
• 7.2. By Material Type
  • 7.2.1. Metal Stents
    • 7.2.1.1. Nitinol Stents
    • 7.2.1.2. Stainless Steel Stents
    • 7.2.1.3. Other Metal Stents
  • 7.2.2. Silicone Stents
  • 7.2.3. Hybrid Stents
• 7.3. By Product Type
  • 7.3.1. Self-expandable Stents
  • 7.3.2. Non-expandable Stents
• 7.4. By End User
  • 7.4.1. Hospitals
  • 7.4.2. Ambulatory Surgical Centers
  • 7.4.3. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. North America Airway stents Market, by Country
    • 7.5.1.1.1. United States
    • 7.5.1.1.2. Canada
    • 7.5.1.1.3. Mexico
  • 7.5.2. Europe
    • 7.5.2.1. Europe Airway stents Market, by Country
    • 7.5.2.1.1. France
    • 7.5.2.1.2. Germany
    • 7.5.2.1.3. United Kingdom
    • 7.5.2.1.4. Italy
    • 7.5.2.1.5. Spain
    • 7.5.2.1.6. Russia
    • 7.5.2.1.7. Rest of Europe
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. Asia-Pacific Airway stents Market, by Country
    • 7.5.3.1.1. China
    • 7.5.3.1.2. Japan
    • 7.5.3.1.3. India
    • 7.5.3.1.4. Australia
    • 7.5.3.1.5. South Korea
    • 7.5.3.1.6. Rest of Asia Pacific
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. RoW Airway stents Market, by Region
    • 7.5.4.1.1. Middle East
    • 7.5.4.1.2. Africa
    • 7.5.4.1.3. South America

8. Airway stents Market Global Company Share Analysis - Key 3-5 Companies

9. Airway stents Market Company and Product Profiles

• 9.1. Boston Scientific Corporation
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. TAEWOONG
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. MICRO-TECH (Nanjing) Co., Ltd.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Novatech SA
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Boston Medical Products Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. HOOD LABORATORIES.
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Merit Medical Systems.
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Cook
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. Meditek Systems Pvt. Ltd.
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Stening SRL
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. Fuji Systems
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Olympus
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. Kapitex Healthcare Ltd
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Teleflex Incorporated.
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. EFER ENDOSCOPY
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us